When we dichotomised patients into initiating trastuzumab ≤12 weeks or >12 weeks from the diagnostic biopsy, patients age, ER and PgR status, tumour grading, and lymph node status did not differ significantly between the two groups. The gene discussed is PGR; the disease is neoplasm.